mRNA Post-Transcriptional Enzymatic Capping Market
完整報告名稱與涵蓋範圍
mRNA Post-Transcriptional Enzymatic Capping Market Size, Share & Trends Analysis Report, By Product Type (Capping Enzymes (Vaccinia and Engineered Variants), 2'-O-Methyltransferases and Cap-1 Conversion Enzymes, Enzymatic Capping Kits and Buffers, Process Development and Analytical Services), By Grade (Research Grade, GMP Grade), By Application (mRNA Vaccines, mRNA Therapeutics and Gene Editing, Self-Amplifying and Long RNA Constructs), By End User, By Region, and Segment Forecasts, 2026-2035
報告摘要
The mRNA post-transcriptional enzymatic capping market covers the capping enzymes, 2'-O-methyltransferases, kits and associated process development and analytical services used to add cap-0 and cap-1 structures to messenger RNA after in vitro transcription. Co-transcriptional cap analogs are addressed in the broader capping technologies study and excluded here; this study concentrates on the enzymatic route and its supply chain.
Enzymatic capping is regaining ground as developers seek to avoid the licensing costs and supply concentration associated with trinucleotide cap analogs, to improve yields for long and self-amplifying RNAs where analog incorporation is inefficient and to obtain near-complete cap-1 conversion. Enzyme manufacturers are engineering variants with higher activity, thermostability and reduced double-stranded RNA by-product formation, supplying animal-origin-free GMP grades with full documentation and offering kits validated across scales. The route adds a process step and requires nucleotide co-substrates and additional purification, so its adoption depends on total cost of goods, process integration in continuous manufacturing platforms and the analytical capability to verify cap structure at release.
North America and Europe host the established enzyme suppliers, while China and South Korea have introduced competitively priced GMP enzymes. Competition involves molecular biology enzyme specialists, diversified life science suppliers, enzyme engineering companies and Asian reagent manufacturers.
The InsightAce study supplies US$ forecasts for all product type, grade, application and end user and regional segments over 2026-2035, segment-level trend analysis, competitive landscape assessment and profiling of the leading companies.
授權報價
| Single User | $4,500 USD |
| Enterprise / Global Site Licence | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global mRNA Post-Transcriptional Enzymatic Capping Market Snapshot
Chapter 4. Global mRNA Post-Transcriptional Enzymatic Capping Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Market Drivers
4.3. Market Challenges
4.4. Emerging Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis - Porter's Five Forces Analysis
4.7. Competitive Landscape and Market Positioning
4.8. Market Opportunity Analysis
Chapter 5. Market Segmentation 1: By Product Type Estimates & Trend Analysis
5.1. Product Type & Market Share, 2026 & 2035
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Product Type:
5.2.1. Capping Enzymes (Vaccinia and Engineered Variants)
5.2.2. 2'-O-Methyltransferases and Cap-1 Conversion Enzymes
5.2.3. Enzymatic Capping Kits and Buffers
5.2.4. Process Development and Analytical Services
Chapter 6. Market Segmentation 2: By Grade Estimates & Trend Analysis
6.1. Grade & Market Share, 2026 & 2035
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Grade:
6.2.1. Research Grade
6.2.2. GMP Grade
Chapter 7. Market Segmentation 3: By Application Estimates & Trend Analysis
7.1. Application & Market Share, 2026 & 2035
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Application:
7.2.1. mRNA Vaccines
7.2.2. mRNA Therapeutics and Gene Editing
7.2.3. Self-Amplifying and Long RNA Constructs
Chapter 8. Market Segmentation 4: By End User Estimates & Trend Analysis
8.1. End User & Market Share, 2026 & 2035
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by End User:
8.2.1. mRNA Developers
8.2.2. CDMOs
8.2.3. Academic and Research Institutes
Chapter 9. mRNA Post-Transcriptional Enzymatic Capping Market: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. United States
9.1.2. Canada
9.2. Europe
9.2.1. Germany
9.2.2. United Kingdom
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia Pacific
9.3.1. China
9.3.2. Japan
9.3.3. India
9.3.4. South Korea
9.3.5. Australia
9.3.6. Southeast Asia
9.3.7. Rest of Asia Pacific
9.4. Latin America
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Middle East & Africa
9.5.1. GCC Countries
9.5.2. South Africa
9.5.3. Rest of Middle East & Africa
Chapter 10. Competitive Landscape
10.1. Company Market Positioning Analysis
10.2. Strategic Developments (Partnerships, Expansions, Product Launches, M&A)
Chapter 11. Company Profiles
11.1. New England Biolabs, Inc.
11.2. Thermo Fisher Scientific Inc.
11.3. Roche CustomBiotech
11.4. Kactus Bio
11.5. Vazyme Biotech Co., Ltd.
11.6. Jena Bioscience GmbH
11.7. Creative Biolabs
11.8. Enzynomics Co., Ltd.
11.9. Codexis, Inc.
11.10. Novozymes (Novonesis)
11.11. Aldevron (Danaher)
11.12. Takara Bio Inc.
11.13. Yeasen Biotechnology (Shanghai) Co., Ltd.
11.14. GenScript Biotech Corporation
11.15. ArcticZymes Technologies ASA
圖表清單 List of Tables & Figures
Table 1. Global mRNA Post-Transcriptional Enzymatic Capping Market Revenue Forecast by Product Type, 2026-2035 (US$ Mn)
Figure 1. Global mRNA Post-Transcriptional Enzymatic Capping Market Segmentation Overview
Table 2. Global mRNA Post-Transcriptional Enzymatic Capping Market Revenue Forecast by Grade, 2026-2035 (US$ Mn)
Figure 2. Global mRNA Post-Transcriptional Enzymatic Capping Market Share by Product Type, 2026 & 2035
Table 3. Global mRNA Post-Transcriptional Enzymatic Capping Market Revenue Forecast by Application, 2026-2035 (US$ Mn)
Figure 3. Enzymatic Capping Process Integration in mRNA Manufacturing Workflows
Table 4. Global mRNA Post-Transcriptional Enzymatic Capping Market Revenue Forecast by End User, 2026-2035 (US$ Mn)
Figure 4. Global mRNA Post-Transcriptional Enzymatic Capping Market Share by Grade, 2026 & 2035
Table 5. North America mRNA Post-Transcriptional Enzymatic Capping Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 5. Engineered Capping Enzyme Performance: Activity, Thermostability and By-Product Reduction
Table 6. Europe mRNA Post-Transcriptional Enzymatic Capping Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 6. Asia Pacific mRNA Post-Transcriptional Enzymatic Capping Growth Opportunity Analysis
Table 7. Asia Pacific mRNA Post-Transcriptional Enzymatic Capping Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 7. GMP Enzyme Supply Landscape and Pricing Trends by Region
Table 8. Latin America mRNA Post-Transcriptional Enzymatic Capping Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 8. Competitive Positioning of Key mRNA Post-Transcriptional Enzymatic Capping Market Participants
Table 9. Middle East & Africa mRNA Post-Transcriptional Enzymatic Capping Market Revenue by Country, 2026-2035 (US$ Mn)
提及公司
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們